Cutaneous metastatic breast carcinoma with clear cell features

Journal of Cutaneous Pathology

Volumn 40, Issue 8, 2013, Pages 753-757

  Shinohara, Michi M ^a   Tozbikian, Gary ^b   Wolfe, Jonathan T ^b   Shin, Sandra J ^c   Mies, Carolyn ^b   Elenitsas, Rosalie ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

clear cell carcinoma; cutaneous metastasis; glycogen rich clear cell carcinoma; metastatic breast carcinoma

Indexed keywords

BREAST TUMOR; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; METASTASIS; MIDDLE AGED; PATHOLOGY; SECONDARY; SKIN TUMOR; XANTHOMATOSIS; ARTICLE; CLEAR CELL CARCINOMA; GLYCOGEN-RICH CLEAR CELL CARCINOMA; METASTATIC BREAST CARCINOMA; SKIN METASTASIS;

BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; SKIN NEOPLASMS; XANTHOMATOSIS;

CLEAR CELL CARCINOMA; CUTANEOUS METASTASIS; GLYCOGEN-RICH CLEAR CELL CARCINOMA; METASTATIC BREAST CARCINOMA;

EID: 84880508216     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12162     Document Type: Article

References (31)

1. American Cancer Society. Breast cancer facts & figures 2009-2010. Atlanta: American Cancer Society, Inc., 2009.
2. Lookingbill DP, Spangler N, Helm KF,. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993; 29: 228.
3. De Giorgi V, Grazzini M, Alfaioli B, et al. Cutaneous manifestations of breast carcinoma. Dermatol Ther 2010; 23: 581.
4. Nashan D, Müller ML, Braun-Falco M, Reichenberger S, Szeimies RM, Bruckner-Tuderman L,. Cutaneous metastases of visceral tumours: a review. J Cancer Res Clin Oncol 2009; 135: 1.
5. Yun SJ, Park HY, Lee JS, Park MH, Lee JB, Won YH,. Clinicopathologic correlation of cutaneous metastatic breast carcinoma using lymphatic and vascular markers: lymphatics are mainly involved in cutaneous metastasis. Clin Exp Dermatol 2012. DOI: 10.1111/j. 1365-2230.2011.04306.x[Epub ahead of print].
6. Requena L, Sánchez Yus E, Nuñez C, White CR Jr, Sangueza OP,. Epidermotropically metastatic breast carcinomas: rare histopathologic variants mimicking melanoma and paget's disease. Am J Dermatopathol 1996; 18: 385.
7. Dina R, Eusebi V,. Clear cell tumors of the breast. Sem Diagnostic Pathol 1997; 14: 175.
8. Hayes MMM, Seidman JD, Ashton MA,. Glycogen-rich clear cell carcinoma of the breast. A clinicopathologic study of 21 cases. Am J Surg Pathol 1995; 19: 904.
9. Kuroda H, Sakamoto G, Ohnisi K, Itoyama S,. Clinical and pathologic features of glycogen-rich clear cell carcinoma of the breast. Breast Cancer 2005; 12: 189.
10. Fujiwara M, Taube J, Sharma M, McCalmont TH, Kim J,. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases. J Cutan Pathol 2010; 37: 938.
11. Perna AG, Ostler DA, Ivan D, et al. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma. J Cutan Pathol 2007; 34: 381.
12. Perna AG, Smith MJ, Krishnan B, Reed JA,. CD10 is expressed in cutaneous clear cell lesions of different histogenesis. J Cutan Pathol 2005; 32: 348.
13. Dhambri S, Zendah I, Avadi-Kaddour A, Adoui O, El Mezni F,. Cutaneous metastasis of lung carcinoma: a retrospective study of 12 cases. J Eur Acad Dermatol Venereol 2011; 25: 722.
14. Stefanou D, Batistatou A, Nonni A, Arkoumani E, Agnantis NJ,. p63 expression in benign and malignant breast lesions. Histol Histopathol 2004; 19: 465.
15. Plaza JA, Ortega PF, Stockman DL, Suster S,. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol 2010; 37: 403.
16. Mahalingam M, Nguyen LP, Richards LE, Muzikansky A, Hoang MP,. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin. Mod Pathol 2010; 23: 713.
17. Tornos C, Soslow R, Chen S, et al. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 2005; 29: 1482.
18. Fernandez-Flores A,. Mammaglobin immunostaining in the differential diagnosis between cutaneous apocrine carcinoma and cutaneous metastasis from breast carcinoma. Cesk Patol 2009; 45: 108.
19. Mano MS, Rosa DD, De Azambuia E, Ismael GF, Durbecq V,. The 17q12-q21 amplicon: Her2 and topoisomerase-II alpha and their importance to the biology of solid tumours. Cancer Treat Rev 2007; 33: 64.
20. Regitnig P, Schippinger W, Lindbauer M, Samonigg H, Lax SF,. Change of HER-2/neu status in a subset of distant metastases from breast carcinomas. J Pathol 2004; 203: 918.
21. Cohen PR, Prieto VG,. Radiation port xanthogranuloma: solitary xanthogranuloma occurring within the irradiated skin of a breast cancer patient-report and review of cutaneous neoplasms developing at the site of radiotherapy. J Cutan Pathol 2010; 37: 891.
22. Lortscher DN, Satter EK, Romero LS,. Signet ring cells: no longer a "signature" of glandular differentiation. Dermatol Online J 2012; 18: 3.
23. Bastian BC, Kutzner H, Yen TSB, LeBoit PE,. Signet-ring cell formation in cutaneous neoplasms. J Am Acad Dermatol 1999; 41: 606.
24. Terada T, Suguira M,. Metastatic hepatocellular carcinoma of skin diagnosed with hepatocyte paraffin 1 and a-fetoprotein immunostainings. Int J Surg Pathol 2010; 18: 433.
25. Styring E, Fernebro J, Jonsson P-E, et al. Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall. Breast Cancer Res Treat 2010; 122: 883.
26. Autio P, Kariniemi AL,. Angiosarcoma. A rare secondary malignancy after breast cancer treatment. Eur J Dermatol 1999; 9: 118.
27. Mattoch IW, Robbins JB, Kempson RL, Kohler S,. Post-radiotherapy vascular proliferations in mammary skin: a clinicopathologic study of 11 cases. J Am Acad Dermatol 2007; 57: 126.
28. Patton KT, Deyrup AT, Weiss SW,. Atypical vascular lesions after surgery and radiation of the breast: a clinicopathologic study of 32 cases analyzing histologic heterogeneity and association with angiosarcoma. Am J Surg Pathol 2008; 32: 943.
29. Walsh N, Rheume D, Barnes P, Tremaine R, Reardon M,. Postirradiation morphea: an underrecognized complication of treatment for breast cancer. Hum Pathol 2008; 39: 1680.
30. Carrasco L, Moreno C, Pastor MA, et al. Postirradiation pseudosclerodermatous panniculitis. Am J Dermatopathol 2001; 23: 283.
31. García-Donoso C, Tardío JC, Arias D, Romero A, Borbujo JM,. Eosinophilic, polymorphic and pruritic eruption associated with radiotherapy (EPPER) in two patients with breast tumour. J Eur Acad Dermatol Venereol 2007; 21: 1102.